The role of the ubiquitin-proteasome system in kidney diseases

Clinical and Experimental Nephrology

Volumn 16, Issue 4, 2012, Pages 507-517

  Fukasawa, Hirotaka ^a  

^a Iwata City Hospital   (Japan)

Author keywords

26S proteasome; E3 ligase; Protein degradation; Ubiquitin

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; HYPOXIA INDUCIBLE FACTOR; PROTEASOME; PROTEINASE; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UBIQUITIN; VON HIPPEL LINDAU PROTEIN;

ACUTE KIDNEY FAILURE; CELL FUNCTION; CHRONIC KIDNEY DISEASE; DISEASE COURSE; HEMODIALYSIS; HOMEOSTASIS; HUMAN; KIDNEY DISEASE; LIDDLE SYNDROME; MUSCLE ATROPHY; NONHUMAN; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

APOPTOSIS; HUMANS; KIDNEY DISEASES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOLYSIS; SIGNAL TRANSDUCTION; UBIQUITIN;

EID: 84865129931     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-012-0643-1     Document Type: Review

References (103)

1. WE Mitch AL Goldberg 1996 Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway N Engl J Med 335 25 1897 1905 8948566 10.1056/NEJM199612193352507 1:CAS:528:DyaK2sXjt1OjtA%3D%3D (Pubitemid 26419198)
2. V Rajan WE Mitch 2008 Ubiquitin, proteasomes and proteolytic mechanisms activated by kidney disease Biochim Biophys Acta 1782 12 795 799 10.1016/j.bbadis.2008.07.007 18723090 10.1016/j.bbadis.2008.07.007 1:CAS:528:DC%2BD1cXhsVCntbzN
3. MH Glickman A Ciechanover 2002 The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction Physiol Rev 82 2 373 428 10.1152/physrev.00027.2001 11917093 1:CAS:528:DC%2BD38XjtFOnsL4%3D (Pubitemid 34654457)
4. E Knecht C Aguado J Carcel I Esteban JM Esteve G Ghislat, et al. 2009 Intracellular protein degradation in mammalian cells: recent developments Cell Mol Life Sci 66 15 2427 2443 10.1007/s00018-009-0030-6 19399586 10.1007/s00018-009-0030-6 1:CAS:528:DC%2BD1MXos1egsLk%3D
5. E Reinstein A Ciechanover 2006 Narrative review: protein degradation and human diseases: the ubiquitin connection Ann Intern Med 145 9 676 684 17088581 (Pubitemid 46768844)
6. K Tanaka 2009 The proteasome: overview of structure and functions Proc Jpn Acad Ser B Phys Biol Sci 85 1 12 36 19145068 10.2183/pjab.85.12 1:CAS:528:DC%2BD1MXjtVyhu7o%3D JST.JSTAGE/pjab/85.12
7. J Massague 1998 TGF-beta signal transduction Annu Rev Biochem 67 753 791 10.1146/annurev.biochem.67.1.753 9759503 10.1146/annurev.biochem.67.1.753 1:CAS:528:DyaK1cXlsFOmsbY%3D (Pubitemid 28411144)
8. WA Border E Ruoslahti 1992 Transforming growth factor-beta in disease: the dark side of tissue repair J Clin Invest 90 1 1 7 10.1172/JCI115821 1634602 10.1172/JCI115821 1:CAS:528:DyaK38XltV2ju7s%3D
9. L Izzi L Attisano 2004 Regulation of the TGFbeta signalling pathway by ubiquitin-mediated degradation Oncogene 23 11 2071 2078 10.1038/sj.onc.1207412 15021894 10.1038/sj.onc.1207412 1:CAS:528:DC%2BD2cXitVOis7w%3D (Pubitemid 38496736)
10. G Monteleone A Kumberova NM Croft C McKenzie HW Steer TT MacDonald 2001 Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease J Clin Invest 108 4 601 609 10.1172/JCI12821 11518734 1:CAS:528:DC%2BD3MXmt1Sqt78%3D (Pubitemid 32777740)
11. C Dong S Zhu T Wang W Yoon Z Li RJ Alvarez, et al. 2002 Deficient Smad7 expression: a putative molecular defect in scleroderma Proc Natl Acad Sci USA 99 6 3908 3913 10.1073/pnas.062010399 11904440 10.1073/pnas.062010399 1:CAS:528:DC%2BD38Xis1Kltbg%3D (Pubitemid 34252204)
12. B Wang J Hao SC Jones MS Yee JC Roth IM Dixon 2002 Decreased Smad 7 expression contributes to cardiac fibrosis in the infarcted rat heart Am J Physiol Heart Circ Physiol 282 5 H1685 H1696 10.1152/ajpheart.00266.2001 11959632 1:CAS:528:DC%2BD38XjslWmtr4%3D
13. H Fukasawa T Yamamoto A Togawa N Ohashi Y Fujigaki T Oda, et al. 2004 Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice Proc Natl Acad Sci USA 101 23 8687 8692 10.1073/pnas.0400035101 15173588 10.1073/pnas. 0400035101 1:CAS:528:DC%2BD2cXltFKksLY%3D (Pubitemid 38745832)
14. Y Tahashi K Matsuzaki M Date K Yoshida F Furukawa Y Sugano, et al. 2002 Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury Hepatology 35 1 49 61 10.1053/jhep.2002.30083 11786959 10.1053/jhep.2002.30083 1:CAS:528:DC%2BD38XmvFaruw%3D%3D (Pubitemid 34032543)
15. J Yang X Zhang Y Li Y Liu 2003 Downregulation of Smad transcriptional corepressors SnoN and Ski in the fibrotic kidney: an amplification mechanism for TGF-beta1 signaling J Am Soc Nephrol 14 12 3167 3177 14638915 10.1097/01.ASN.0000099373.33259.B2 1:CAS:528:DC%2BD3sXptVClsbg%3D (Pubitemid 38312571)
16. Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH et al. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol Cell. 2000;6(6):1365-75. pii: S1097-2765(00)00134- 9. (Pubitemid 32045929)
17. T Ebisawa M Fukuchi G Murakami T Chiba K Tanaka T Imamura, et al. 2001 Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation J Biol Chem 276 16 12477 12480 10.1074/jbc.C100008200 11278251 10.1074/jbc.C100008200 1:CAS:528: DC%2BD3MXjtFynsbk%3D
18. S Bonni HR Wang CG Causing P Kavsak SL Stroschein K Luo, et al. 2001 TGF-beta induces assembly of a Smad2-Smurf2 ubiquitin ligase complex that targets SnoN for degradation Nat Cell Biol 3 6 587 595 10.1038/35078562 11389444 10.1038/35078562 1:CAS:528:DC%2BD3MXksFelurk%3D (Pubitemid 32536856)
19. H Zhu P Kavsak S Abdollah JL Wrana GH Thomsen 1999 A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation Nature 400 6745 687 693 10.1038/23293 10458166 10.1038/23293 1:CAS:528: DyaK1MXlsVCrs78%3D (Pubitemid 29382575)
20. X Lin M Liang XH Feng 2000 Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-beta signaling J Biol Chem 275 47 36818 36822 10.1074/jbc.C000580200 11016919 10.1074/jbc.C000580200 1:CAS:528:DC%2BD3cXoslWls74%3D (Pubitemid 32002092)
21. Y Asano H Ihn K Yamane M Kubo K Tamaki 2004 Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts J Clin Invest 113 2 253 264 10.1172/JCI16269 14722617 1:CAS:528:DC%2BD2cXmsVyqsg%3D%3D (Pubitemid 38544210)
22. N Ohashi T Yamamoto C Uchida A Togawa H Fukasawa Y Fujigaki, et al. 2005 Transcriptional induction of Smurf2 ubiquitin ligase by TGF-beta FEBS Lett 579 12 2557 2563 10.1016/j.febslet.2005.03.069 15862290 10.1016/j.febslet.2005.03. 069 1:CAS:528:DC%2BD2MXjvVOhuro%3D (Pubitemid 40615658)
23. R Tan W He X Lin LP Kiss Y Liu 2008 Smad ubiquitination regulatory factor-2 in the fibrotic kidney: regulation, target specificity, and functional implication Am J Physiol Renal Physiol 294 5 F1076 F1083 10.1152/ajprenal.00323. 2007 18353873 10.1152/ajprenal.00323.2007 1:CAS:528:DC%2BD1cXmtVWntb0%3D
24. A Togawa T Yamamoto H Suzuki H Fukasawa N Ohashi Y Fujigaki, et al. 2003 Ubiquitin-dependent degradation of Smad2 is increased in the glomeruli of rats with anti-thymocyte serum nephritis Am J Pathol 163 4 1645 1652 14507671 10.1016/S0002-9440(10)63521-3 1:CAS:528:DC%2BD3sXotlegtLk%3D (Pubitemid 37175111)
25. H Fukasawa T Yamamoto A Togawa N Ohashi Y Fujigaki T Oda, et al. 2006 Ubiquitin-dependent degradation of SnoN and Ski is increased in renal fibrosis induced by obstructive injury Kidney Int 69 10 1733 1740 10.1038/sj.ki.5000261 16625151 10.1038/sj.ki.5000261 1:CAS:528:DC%2BD28XksVGntrw%3D (Pubitemid 43739199)
26. D Koinuma M Shinozaki A Komuro K Goto M Saitoh A Hanyu, et al. 2003 Arkadia amplifies TGF-beta superfamily signalling through degradation of Smad7 EMBO J 22 24 6458 6470 10.1093/emboj/cdg632 14657019 10.1093/emboj/cdg632 1:CAS:528:DC%2BD3sXpvVemtL0%3D (Pubitemid 38009594)
27. W Liu H Rui J Wang S Lin Y He M Chen, et al. 2006 Axin is a scaffold protein in TGF-beta signaling that promotes degradation of Smad7 by Arkadia EMBO J 25 8 1646 1658 10.1038/sj.emboj.7601057 16601693 10.1038/sj.emboj.7601057 1:CAS:528:DC%2BD28XjsFakt70%3D
28. FY Liu XZ Li YM Peng H Liu YH Liu 2007 Arkadia-Smad7-mediated positive regulation of TGF-beta signaling in a rat model of tubulointerstitial fibrosis Am J Nephrol 27 2 176 183 10.1159/000100518 17347560 (Pubitemid 46588184)
29. FY Liu XZ Li YM Peng H Liu YH Liu 2008 Arkadia regulates TGF-beta signaling during renal tubular epithelial to mesenchymal cell transition Kidney Int 73 5 588 594 10.1038/sj.ki.5002713 18059455 10.1038/sj.ki.5002713 1:CAS:528:DC%2BD1cXhvFCmsLw%3D (Pubitemid 351264107)
30. Cheema B, Abas H, Smith B, O'Sullivan AJ, Chan M, Patwardhan A, et al. Investigation of skeletal muscle quantity and quality in end-stage renal disease. Nephrology (Carlton). 15(4):454-63. doi: 10.1111/j.1440-1797.2009. 01261.x.
31. AR Qureshi A Alvestrand A Danielsson JC Divino-Filho A Gutierrez B Lindholm, et al. 1998 Factors predicting malnutrition in hemodialysis patients: a cross-sectional study Kidney Int 53 3 773 782 10.1046/j.1523-1755.1998.00812.x 9507226 10.1046/j.1523-1755.1998.00812.x 1:STN:280:DyaK1c7mvVSltQ%3D%3D (Pubitemid 28124295)
32. RR Wolfe 2006 The underappreciated role of muscle in health and disease Am J Clin Nutr 84 3 475 482 16960159 1:CAS:528:DC%2BD28XpvVCqt7k%3D (Pubitemid 44713395)
33. VS Lim JD Kopple 2000 Protein metabolism in patients with chronic renal failure: role of uremia and dialysis Kidney Int 58 1 1 10 10.1046/j.1523-1755. 2000.00135.x 10886544 10.1046/j.1523-1755.2000.00135.x 1:CAS:528: DC%2BD3cXltVyjtrc%3D (Pubitemid 30429844)
34. PO Hasselgren JH James DW Benson M Hall-Angeras U Angeras DT Hiyama, et al. 1989 Total and myofibrillar protein breakdown in different types of rat skeletal muscle: effects of sepsis and regulation by insulin Metabolism 38 7 634 640 2661965 10.1016/0026-0495(89)90100-5 1:CAS:528:DyaL1MXktlOht7o%3D (Pubitemid 19174307)
35. G Tiao JM Fagan N Samuels JH James K Hudson M Lieberman, et al. 1994 Sepsis stimulates nonlysosomal, energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle J Clin Invest 94 6 2255 2264 10.1172/JCI117588 7989581 10.1172/JCI117588 1:CAS:528:DyaK2MXisFWhtbs%3D (Pubitemid 24379596)
36. CH Fang G Tiao H James C Ogle JE Fischer PO Hasselgren 1995 Burn injury stimulates multiple proteolytic pathways in skeletal muscle, including the ubiquitin-energy-dependent pathway J Am Coll Surg 180 2 161 170 7850049 1:STN:280:DyaK2M7lt1yqsg%3D%3D
37. DH Lawson A Richmond DW Nixon D Rudman 1982 Metabolic approaches to cancer cachexia Annu Rev Nutr 2 277 301 10.1146/annurev.nu.02.070182.001425 6821191 10.1146/annurev.nu.02.070182.001425 1:CAS:528:DyaL3sXitFemsLk%3D
38. VE Baracos C DeVivo DH Hoyle AL Goldberg 1995 Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma Am J Physiol 268 5 Pt 1 E996 E1006 7539218 1:CAS:528:DyaK2MXlvVaisrs%3D
39. S Temparis M Asensi D Taillandier E Aurousseau D Larbaud A Obled, et al. 1994 Increased ATP-ubiquitin-dependent proteolysis in skeletal muscles of tumor-bearing rats Cancer Res 54 21 5568 5573 7923198 1:CAS:528: DyaK2cXmvFyitr0%3D (Pubitemid 24346248)
40. X Wang Z Hu J Hu J Du WE Mitch 2006 Insulin resistance accelerates muscle protein degradation: activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling Endocrinology 147 9 4160 4168 10.1210/en.2006-0251 16777975 10.1210/en.2006-0251 1:CAS:528:DC%2BD28Xpt1SjtLk%3D (Pubitemid 44268367)
41. D Reaich SM Channon CM Scrimgeour SE Daley R Wilkinson TH Goodship 1993 Correction of acidosis in humans with CRF decreases protein degradation and amino acid oxidation Am J Physiol 265 2 Pt 1 E230 E235 8396331 1:CAS:528:DyaK2cXmtFyq
42. KA Graham D Reaich SM Channon S Downie TH Goodship 1997 Correction of acidosis in hemodialysis decreases whole-body protein degradation J Am Soc Nephrol 8 4 632 637 10495793 1:STN:280:DyaK1MvisFyjsg%3D%3D
43. WP Pickering SR Price G Bircher AC Marinovic WE Mitch J Walls 2002 Nutrition in CAPD: serum bicarbonate and the ubiquitin-proteasome system in muscle Kidney Int 61 4 1286 1292 10.1046/j.1523-1755.2002.00276.x 11918735 10.1046/j.1523-1755.2002.00276.x 1:CAS:528:DC%2BD38XjtVGqtrk%3D (Pubitemid 34304489)
44. WE Mitch R Medina S Grieber RC May BK England SR Price, et al. 1994 Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes J Clin Invest 93 5 2127 2133 10.1172/JCI117208 8182144 10.1172/JCI117208 1:CAS:528:DyaK2cXivFGqu7w%3D (Pubitemid 24143094)
45. SR Price JL Bailey X Wang C Jurkovitz BK England X Ding, et al. 1996 Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-proteasome proteolytic pathway by a mechanism including gene transcription J Clin Invest 98 8 1703 1708 10.1172/JCI118968 8878419 10.1172/JCI118968 1:CAS:528:DyaK28XmtlOgtLg%3D (Pubitemid 26359185)
46. P Stenvinkel O Heimburger F Paultre U Diczfalusy T Wang L Berglund, et al. 1999 Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure Kidney Int 55 5 1899 1911 10.1046/j.1523-1755.1999.00422.x 10231453 10.1046/j.1523-1755.1999.00422.x 1:STN:280:DyaK1M3ltV2msQ%3D%3D (Pubitemid 29197978)
47. YH Song Y Li J Du WE Mitch N Rosenthal P Delafontaine 2005 Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting J Clin Invest. 115 2 451 458 10.1172/JCI22324 15650772 1:CAS:528:DC%2BD2MXhtFyjtr8%3D (Pubitemid 40385487)
48. RC May RA Kelly WE Mitch 1986 Metabolic acidosis stimulates protein degradation in rat muscle by a glucocorticoid-dependent mechanism J Clin Invest 77 2 614 621 10.1172/JCI112344 3511100 10.1172/JCI112344 1:CAS:528: DyaL28Xht1Olur0%3D (Pubitemid 16037664)
49. Z Hu H Wang IH Lee J Du WE Mitch 2009 Endogenous glucocorticoids and impaired insulin signaling are both required to stimulate muscle wasting under pathophysiological conditions in mice J Clin Invest 119 10 3059 3069 10.1172/JCI38770 19759515 1:CAS:528:DC%2BD1MXht1GjurzK
50. JL Bailey B Zheng Z Hu SR Price WE Mitch 2006 Chronic kidney disease causes defects in signaling through the insulin receptor substrate/ phosphatidylinositol 3-kinase/Akt pathway: implications for muscle atrophy J Am Soc Nephrol 17 5 1388 1394 10.1681/ASN.2004100842 16611720 10.1681/ASN. 2004100842 1:CAS:528:DC%2BD28XkvVKrsbw%3D (Pubitemid 43673419)
51. J Du X Wang C Miereles JL Bailey R Debigare B Zheng, et al. 2004 Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions J Clin Invest 113 1 115 123 10.1172/JCI18330 14702115 1:CAS:528:DC%2BD2cXjsVGltw%3D%3D (Pubitemid 38541638)
52. SC Bodine E Latres S Baumhueter VK Lai L Nunez BA Clarke, et al. 2001 Identification of ubiquitin ligases required for skeletal muscle atrophy Science 294 5547 1704 1708 10.1126/science.1065874 11679633 10.1126/science.1065874 1:CAS:528:DC%2BD3MXoslCjs74%3D (Pubitemid 33104839)
53. SH Lecker RT Jagoe A Gilbert M Gomes V Baracos J Bailey, et al. 2004 Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression FASEB J 18 1 39 51 10.1096/fj.03-0610com 14718385 10.1096/fj.03-0610com 1:CAS:528:DC%2BD2cXmt1KgsA%3D%3D (Pubitemid 38076464)
54. SW Lee G Dai Z Hu X Wang J Du WE Mitch 2004 Regulation of muscle protein degradation: coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 kinase J Am Soc Nephrol 15 6 1537 1545 15153564 10.1097/01.ASN.0000127211.86206.E1 1:CAS:528:DC%2BD2cXktVWiurw%3D (Pubitemid 38679678)
55. K Polyak JY Kato MJ Solomon CJ Sherr J Massague JM Roberts, et al. 1994 p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest Genes Dev 8 1 9 22 8288131 10.1101/gad.8.1.9 1:CAS:528:DyaK2cXktVWku7c%3D
56. Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, et al. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell. 1994;78(1):59-66. pii: 0092-8674(94)90572-X.
57. N Kawamata R Morosetti CW Miller D Park KS Spirin T Nakamaki, et al. 1995 Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies Cancer Res 55 11 2266 2269 7757974 1:CAS:528: DyaK2MXlvFeru70%3D
58. R Morosetti N Kawamata AF Gombart CW Miller Y Hatta T Hirama, et al. 1995 Alterations of the p27KIP1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma Blood 86 5 1924 1930 7655021 1:CAS:528:DyaK2MXnslKru7s%3D
59. M Shimada K Kitagawa Y Dobashi T Isobe T Hattori C Uchida, et al. 2009 High expression of Pirh2, an E3 ligase for p27, is associated with low expression of p27 and poor prognosis in head and neck cancers Cancer Sci 100 5 866 872 19445020 10.1111/j.1349-7006.2009.01122.x 1:CAS:528:DC%2BD1MXls1Srtbo%3D
60. V Esposito A Baldi A De Luca AM Groger M Loda GG Giordano, et al. 1997 Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer Cancer Res 57 16 3381 3385 9270000 1:CAS:528:DyaK2sXls1Shtbk%3D (Pubitemid 27355479)
61. GV Thomas K Szigeti M Murphy G Draetta M Pagano M Loda 1998 Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases Am J Pathol 153 3 681 687 9736017 10.1016/S0002- 9440(10)65610-6 1:CAS:528:DyaK1cXmtFKntbg%3D (Pubitemid 28419021)
62. M Ciaparrone H Yamamoto Y Yao A Sgambato G Cattoretti N Tomita, et al. 1998 Localization and expression of p27KIP1 in multistage colorectal carcinogenesis Cancer Res 58 1 114 122 9426067 1:CAS:528:DyaK1cXitVGltg%3D%3D (Pubitemid 28027726)
63. AC Carrano E Eytan A Hershko M Pagano 1999 SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 Nat Cell Biol 1 4 193 199 10559916 10.1038/12013 1:CAS:528:DyaK1MXltlSjtr0%3D (Pubitemid 129500937)
64. M Gstaiger R Jordan M Lim C Catzavelos J Mestan J Slingerland, et al. 2001 Skp2 is oncogenic and overexpressed in human cancers Proc Natl Acad Sci USA 98 9 5043 5048 10.1073/pnas.081474898 11309491 10.1073/pnas.081474898 1:CAS:528:DC%2BD3MXjt1Ogu7c%3D (Pubitemid 32397079)
65. R Palmqvist R Stenling A Oberg G Landberg 1999 Prognostic significance of p27(Kip1) expression in colorectal cancer: a clinico-pathological characterization J Pathol 188 1 18 23 10.1002/(SICI)1096-9896(199905)188: 1<18::AID-PATH311>3.0.CO;2-T 10398135 10.1002/(SICI)1096-9896(199905)188: 1<18::AID-PATH311>3.0.CO;2-T 1:STN:280:DyaK1MzlvFGltA%3D%3D (Pubitemid 29197309)
66. P Tan B Cady M Wanner P Worland B Cukor C Magi-Galluzzi, et al. 1997 The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a, b) invasive breast carcinomas Cancer Res 57 7 1259 1263 9102210 1:CAS:528:DyaK2sXit1Ojtb8%3D (Pubitemid 27152548)
67. RJ Cote Y Shi S Groshen AC Feng C Cordon-Cardo D Skinner, et al. 1998 Association of p27Kip1 levels with recurrence and survival in patients with stage C prostate carcinoma J Natl Cancer Inst 90 12 916 920 9637141 10.1093/jnci/90.12.916 1:STN:280:DyaK1c3pvFaisw%3D%3D (Pubitemid 28304160)
68. AB Chkhotua D Abendroth G Froeba H Schelzig 2006 Up-regulation of cell cycle regulatory genes after renal ischemia/reperfusion: differential expression of p16(INK4a), p21(WAF1/CIP1) and p27(Kip1) cyclin-dependent kinase inhibitor genes depending on reperfusion time Transpl Int 19 1 72 77 10.1111/j.1432-2277. 2005.00227.x 16359379 10.1111/j.1432-2277.2005.00227.x 1:CAS:528: DC%2BD28XitVCrs7s%3D
69. JH Gerth J Kriegsmann TT Trinh RA Stahl T Wendt M Sommer, et al. 2002 Induction of p27KIP1 after unilateral ureteral obstruction is independent of angiotensin II Kidney Int 61 1 68 79 10.1046/j.1523-1755.2002.00111.x 11786086 10.1046/j.1523-1755.2002.00111.x 1:CAS:528:DC%2BD38XlslGntg%3D%3D (Pubitemid 34075132)
70. Y Terada S Inoshita O Nakashima T Yamada M Kuwahara S Sasaki, et al. 1998 Lovastatin inhibits mesangial cell proliferation via p27Kip1 J Am Soc Nephrol 9 12 2235 2243 9848777 1:CAS:528:DyaK1cXotVKnsrw%3D (Pubitemid 28543801)
71. K Hiromura JW Pippin ML Fero JM Roberts SJ Shankland 1999 Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27(Kip1) J Clin Invest 103 5 597 604 10.1172/JCI5461 10074476 10.1172/JCI5461 1:CAS:528:DyaK1MXhsF2isro%3D (Pubitemid 29122412)
72. V Ophascharoensuk ML Fero J Hughes JM Roberts SJ Shankland 1998 The cyclin-dependent kinase inhibitor p27Kip1 safeguards against inflammatory injury Nat Med 4 5 575 580 9585231 10.1038/nm0598-575 1:CAS:528:DyaK1cXjtFGruro%3D (Pubitemid 28237356)
73. S Suzuki H Fukasawa K Kitagawa C Uchida T Hattori T Isobe, et al. 2007 Renal damage in obstructive nephropathy is decreased in Skp2-deficient mice Am J Pathol 171 2 473 483 10.2353/ajpath.2007.070279 17620370 10.2353/ajpath.2007. 070279 1:CAS:528:DC%2BD2sXpsFaiuro%3D (Pubitemid 47344680)
74. S Suzuki H Fukasawa T Misaki A Togawa N Ohashi K Kitagawa, et al. 2011 Up-regulation of Cks1 and Skp2 with TNFalpha/NF-kappaB signaling in chronic progressive nephropathy Genes Cells 16 11 1110 1120 10.1111/j.1365-2443.2011. 01553.x 22017545 10.1111/j.1365-2443.2011.01553.x 1:CAS:528:DC%2BC3MXhsFSjsrzJ
75. GW Liddle T Bledsoe WSJ Coppage 1963 A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion Trans Assoc Am Physicians 76 199 213 1:CAS:528:DyaF2cXktVKltrY%3D
76. M Botero-Velez JJ Curtis DG Warnock 1994 Brief report: Liddle's syndrome revisited-a disorder of sodium reabsorption in the distal tubule N Engl J Med 330 3 178 181 8264740 10.1056/NEJM199401203300305 1:STN:280: DyaK2c%2FovVKrtA%3D%3D
77. + channel (ENaC) by ubiquitination EMBO J 16 21 6325 6336 10.1093/emboj/16.21.6325 9351815 10.1093/emboj/16.21.6325 1:CAS:528:DyaK2sXnslWksbk%3D (Pubitemid 27483259)
78. Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M, et al. Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell. 1994;79(3):407-14. pii: 0092-8674(94)90250-X. (Pubitemid 24346056)
79. + channel J Biol Chem 278 22 20019 20028 10.1074/jbc.M211153200 12654927 10.1074/jbc.M211153200 1:CAS:528: DC%2BD3sXktVaqur4%3D (Pubitemid 36799195)
80. V Kanelis MC Bruce NR Skrynnikov D Rotin JD Forman-Kay 2006 Structural determinants for high-affinity binding in a Nedd4 WW3*domain-Comm PY motif complex Structure 14 3 543 553 10.1016/j.str.2005.11.018 16531238 10.1016/j.str.2005.11.018 1:CAS:528:DC%2BD28Xit1yltr0%3D (Pubitemid 43363487)
81. D Loffing-Cueni SY Flores D Sauter D Daidie N Siegrist P Meneton, et al. 2006 Dietary sodium intake regulates the ubiquitin-protein ligase nedd4-2 in the renal collecting system J Am Soc Nephrol 17 5 1264 1274 10.1681/ASN.2005060659 16571785 10.1681/ASN.2005060659 1:CAS:528:DC%2BD28XkvVKrsr0%3D (Pubitemid 43673406)
82. + channel by Nedd4 in Liddle's syndrome J Clin Invest 103 5 667 673 10.1172/JCI5713 10074483 10.1172/JCI5713 1:CAS:528:DyaK1MXhsF2is78%3D (Pubitemid 29122419)
83. + channel FASEB J 15 1 204 214 10.1096/fj.00-0191com 11149908 10.1096/fj.00-0191com 1:CAS:528:DC%2BD3MXht1Snsbo%3D (Pubitemid 32061671)
84. C Lu S Pribanic A Debonneville C Jiang D Rotin 2007 The PY motif of ENaC, mutated in Liddle syndrome, regulates channel internalization, sorting and mobilization from subapical pool Traffic 8 9 1246 1264 10.1111/j.1600-0854.2007. 00602.x 17605762 10.1111/j.1600-0854.2007.00602.x 1:CAS:528:DC%2BD2sXhtVeht7vF (Pubitemid 47244875)
85. C Debonneville SY Flores E Kamynina PJ Plant C Tauxe MA Thomas, et al. 2001 Phosphorylation of Nedd4-2 by Sgk1 regulates epithelial Na(+) channel cell surface expression EMBO J 20 24 7052 7059 10.1093/emboj/20.24.7052 11742982 10.1093/emboj/20.24.7052 1:CAS:528:DC%2BD38XpsFOh (Pubitemid 34062297)
86. F Latif K Tory J Gnarra M Yao FM Duh ML Orcutt, et al. 1993 Identification of the von Hippel-Lindau disease tumor suppressor gene Science 260 5112 1317 1320 8493574 10.1126/science.8493574 1:CAS:528:DyaK3sXks12htbc%3D (Pubitemid 23231974)
87. WK Rathmell S Chen 2008 VHL inactivation in renal cell carcinoma: implications for diagnosis, prognosis and treatment Expert Rev Anticancer Ther 8 1 63 73 10.1586/14737140.8.1.63 18095884 10.1586/14737140.8.1.63 1:CAS:528:DC%2BD2sXhsVGju7zP
88. ME Cockman N Masson DR Mole P Jaakkola GW Chang SC Clifford, et al. 2000 Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein J Biol Chem 275 33 25733 25741 10.1074/jbc.M002740200 10823831 10.1074/jbc.M002740200 1:CAS:528: DC%2BD3cXmtVeht7o%3D
89. 2-regulated gene expression FASEB J 16 10 1151 1162 10.1096/fj.01-0944rev 12153983 10.1096/fj.01-0944rev 1:CAS:528: DC%2BD38XlslWrs78%3D (Pubitemid 34815403)
90. SC Clifford ME Cockman AC Smallwood DR Mole ER Woodward PH Maxwell, et al. 2001 Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease Hum Mol Genet 10 10 1029 1038 11331613 10.1093/hmg/10.10.1029 1:CAS:528:DC%2BD3MXjslyqtLs%3D (Pubitemid 32447780)
91. MA Maynard M Ohh 2005 Molecular targets from VHL studies into the oxygen-sensing pathway Curr Cancer Drug Targets 5 5 345 356 16101382 10.2174/1568009054629672 1:CAS:528:DC%2BD2MXntFCnurk%3D (Pubitemid 41097758)
92. M Iguchi Y Kakinuma A Kurabayashi T Sato T Shuin SB Hong, et al. 2008 Acute inactivation of the VHL gene contributes to protective effects of ischemic preconditioning in the mouse kidney Nephron Exp Nephrol 110 3 e82 e90 10.1159/000166994 18957870 10.1159/000166994 1:CAS:528:DC%2BD1cXhsVaisLnL
93. PP Kapitsinou VH Haase 2008 The VHL tumor suppressor and HIF: insights from genetic studies in mice Cell Death Differ 15 4 650 659 10.1038/sj.cdd. 4402313 18219317 10.1038/sj.cdd.4402313 1:CAS:528:DC%2BD1cXjtl2isr0%3D (Pubitemid 351405068)
94. MJ Percy PW Furlow GS Lucas X Li TR Lappin MF McMullin, et al. 2008 A gain-of-function mutation in the HIF2A gene in familial erythrocytosis N Engl J Med 358 2 162 168 10.1056/NEJMoa073123 18184961 10.1056/NEJMoa073123 1:CAS:528:DC%2BD1cXltFahtQ%3D%3D
95. WM Bernhardt MS Wiesener A Weidemann R Schmitt W Weichert P Lechler, et al. 2007 Involvement of hypoxia-inducible transcription factors in polycystic kidney disease Am J Pathol 170 3 830 842 10.2353/ajpath.2007.060455 17322369 10.2353/ajpath.2007.060455 1:CAS:528:DC%2BD2sXjs1Wls7s%3D (Pubitemid 47339353)
96. RA Star 1998 Treatment of acute renal failure Kidney Int 54 6 1817 1831 10.1046/j.1523-1755.1998.00210.x 9853246 10.1046/j.1523-1755.1998.00210.x 1:STN:280:DyaK1M%2FntVemug%3D%3D (Pubitemid 28533609)
97. M Itoh M Takaoka A Shibata M Ohkita Y Matsumura 2001 Preventive effect of lactacystin, a selective proteasome inhibitor, on ischemic acute renal failure in rats J Pharmacol Exp Ther 298 2 501 507 11454911 1:CAS:528: DC%2BD3MXlsVKqs7Y%3D (Pubitemid 32673400)
98. Takaoka M, Itoh M, Hayashi S, Kuro T, Matsumura Y. Proteasome participates in the pathogenesis of ischemic acute renal failure in rats. Eur J Pharmacol. 1999;384(1):43-6. pii: S0014-2999(99)00664-0.
99. M Takaoka M Itoh S Kohyama A Shibata M Ohkita Y Matsumura 2000 Proteasome inhibition attenuates renal endothelin-1 production and the development of ischemic acute renal failure in rats J Cardiovasc Pharmacol 36 5 Suppl 1 S225 S227 11078383 1:CAS:528:DC%2BD3cXnslKju7w%3D
100. P Quehenberger A Bierhaus P Fasching C Muellner M Klevesath M Hong, et al. 2000 Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells Diabetes 49 9 1561 1570 10969841 10.2337/diabetes.49.9.1561 1:CAS:528:DC%2BD3cXmsVOrsbY%3D
101. V Jesenberger S Jentsch 2002 Deadly encounter: ubiquitin meets apoptosis Nat Rev Mol Cell Biol 3 2 112 121 10.1038/nrm731 11836513 10.1038/nrm731 1:CAS:528:DC%2BD38XhsFSrs78%3D
102. JM Huber A Tagwerker D Heininger G Mayer AR Rosenkranz K Eller 2009 The proteasome inhibitor bortezomib aggravates renal ischemia-reperfusion injury Am J Physiol Renal Physiol 297 2 F451 F460 10.1152/ajprenal.90576.2008 19458122 10.1152/ajprenal.90576.2008 1:CAS:528:DC%2BD1MXhtVaht7vP
103. Liu L, Yang C, Herzog C, Seth R, Kaushal GP. Proteasome inhibitors prevent cisplatin-induced mitochondrial release of apoptosis-inducing factor and markedly ameliorate cisplatin nephrotoxicity. Biochem Pharmacol. 79(2):137-46. doi: 10.1016/j.bcp.2009.08.015.